Multicentre European study of thalamic stimulation in parkinsonian and essential tremor

Journal of Neurology Neurosurgery and Psychiatry

Volumn 66, Issue 3, 1999, Pages 289-296

  Limousin, P ^a,b   Speelman, J D ^c   Gielen, F ^d   Janssens, M ^d  

^a UNIV GRENOBLE ALPES   (France)

^b MEDICAL RESEARCH COUNCIL   (United Kingdom)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d MEDTRONIC BAKKEN RESEARCH CENTER   (Netherlands)

Author keywords

Essential tremor; Parkinson's disease; Thalamic stimulation

Indexed keywords

CHOLINERGIC RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; MONOAMINE OXIDASE B INHIBITOR; PRIMIDONE; PROPRANOLOL;

ADULT; AGED; AKINESIA; ARM; ARTICLE; CLINICAL TRIAL; DAILY LIFE ACTIVITY; DISABILITY; DRUG THERAPY; ELECTRODE; ELECTROSTIMULATION THERAPY; ESSENTIAL TREMOR; EUROPE; FEMALE; HEAD; HUMAN; IMPLANT; LEG; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PARKINSON DISEASE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; REST; RIGIDITY; THALAMUS; VOICE;

EID: 0032954029     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.66.3.289     Document Type: Article

References (40)

1. Hassler R, Riechert T. Indikationen und lokalisationsmethode der gezielten hirnoperationen. Nervenartz 1954;25:441-7.
2. Hurtig HI, Stern MB. Thalamotomy for Parkinson's disease [letter]. J Neurosurg 1985;62:163-5.
3. Benabid AL, Pollak P, Louveau A, et al. Combined (thalamotomy and stimulation) stereotactic surgery of the VIM thalamic nucleus for bilateral Parkinson disease. Appl Neurophysiol 1987;50:344-6.
4. Bechtereva NP, Kambarova DK, Smirnov MV, et al. Using the brain's latent abilities for therapy: chronic intracerebral electrical stimulation. In: Sweet WH, Obrador S, Martin-Rodriguez JG, eds. Neurosurgical treatment in psychiatry, pain and epilepsy. Baltimore: University Park Press,1975: 581-613.
5. Brice J, McLellan. Suppression of intention tremor by contingent deep brain stimulation. Lancet 1980;i:1221-2.
6. Mazars G, Merienne L, Cioloca C. Control of dyskinesias due to sensory deafferentation by means of thalamic stimulation. Acta Neurochir Suppl 1980;30:239-13.
7. Andy OJ. Thalamic stimulation for control of movement disorders. Appl Neurophysiol 1983;46:107-11.
8. Siegfried J. Effet de la stimulation du noyau sensitif du thalamus sur les dyskinésíes et la spasticité. Rev Neurol 1986;142:380-3.
9. Benabid AL, Pollak P, Gervason C, et al. Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus. Lancet 1991;337:403-6.
10. Blond S, Siegfried J. Thalamic stimulation for the treatment of tremor and other movement disorders. Acta Neurochir 1991;52:109-11.
11. Blond S, Caparros Lefebvre D, Parker F, et al. Control of tremor and involuntary movement disorders by chronic stereotactic stimulation of the ventral intermediate thalamic nucleus. J Neurosurg 1992;77:62-8.
12. Caparros Lefebvre D, Blond S, Vermersch P, et al. Chronic thalamic stimulation improves tremor and levodopa induced dyskinesias in Parkinson's disease. J Neurol Neurosurg Psychiatry 1993;56:268-73.
13. Speelman JD, Bosch DA. Continuous electrical stimulation of the thalamus in the treatment of drug resistant tremor. Ned Tijdschr Geneeskd 1995;138:926-30.
14. Alesch F, Pinter MM, Helscher RJ, et al. Stimulation of the ventral intermediate thalamic nucleus in tremor dominated Parkinson's disease and essential tremor. Acta Neurochir 1995;136:75-81.
15. Koller W, Hristova A. Efficacy and safety of stereotaxic surgical treatment of tremor disorders. European Journal of Neurology 1996;3:507-14.
16. Koller E, Pahwa R, Busenbark K, et al. High-frequency unilateral thalamic stimulation in the treatment of essential and parkinsonian tremor. Ann Neurol 1997;42:292-9.
17. Hariz GM, Bergenheim AT, Hariz MI, et al. Assessment of ability/disability in patients treated with chronic thalamic stimulation for tremor. Mov Disord 1998;13:78-83.
18. Fahn S, Elton R. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne D, et al, eds. Recent developments in Parkinson's disease. Vol II. Florham Park: MacMillan Healthcare Information, 1987:153-63
19. Fahn S, Tolosa E, Marin C. Clinical rating scale for tremor. In: Jankovic J, Tolosa E. eds. Parkinson's disease and movement disorders. Munich, Urban, and Schwarzenberg, 1988:225-34.
20. Carpenter MA, Pahwa R, Miyawaki KL, et al. Reduction of voice tremor under thalamic stimulation. Neurology 1998; 50:796-8.
21. Pollak P, Benabid AL, Limousin P, et al. Chronic intracerebral stimulation in Parkinson's disease. Adv Neurol 1997;74:213-20.
22. Speelman JD. Parkinson's disease and stereotaxic neurosurgery. Amsterdam: Thesis, 1991.
23. Defebvre L, Blatt JL, Blond S, et al. Effect of thalamic stimulation on gait in Parkinson disease. Arch Neurol 1996,53:898-903.
24. Laitinen LV, Bergenheim AT, Hariz MI. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg 1992;76:53-61.
25. Lang AE, Lozano AM, Montgomery E, et al. Posteroventral medial pallidotomy in advanced Parkinson's disease. N Engl J Med 1997;337:1036-42.
26. Siegfried J, Lippitz B. Bilateral chronic electrosumulation of ventroposterolateral pallidum: a new therapeutic approach for alleviating all parkinsonian symptoms. Neurosurgery 1994;35:1126-9.
27. Limousin P, Pollak P, Benazzouz A, et al. Effect of parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 1995;345:91-5.
28. Krack P, Pollak P, Limousin P, et al. Stimulation of the subthalamic nucleus alleviates tremor in Parkinson's disease. Lancet 1997;350:1675.
29. Benabid AL, Blond S, Pollak P, et al. Electrical neurpinhibition of CMPf is effective on tremor and L-dopa induced dyskinesias in Parkinson's disease. Neurology 1997;48:A357.
30. Caparros Lefebvre D, Blond S, Pecheux N, et al. Neuropsychological evaluation before and after thalamic stimulation in nine patients with Parkinson disease. Rev Neurol 1992;148:117-22.
31. Troster AI, Fields JA, Wilkinson SB, et al. Neuropsychological functioning before and after unilateral thalamic stimulating electrode implantation in Parkinson's disease. Neurosurgical Focus 1997;2:1-6.
32. Schuurman PR, Speelman JD, Bosch DA. Thalamic stimulation versus thalamotomy in a prospective randomized trial. In: Abstracts of oral presentations, 12th Meeting of the World Society for Stereotactic and Functional Neurosurgery, Lyon: WSSFN, 1997:38.
33. Siegfried J. Neurosurgical treatment of Parkinson's disease. Present indications and value. In: Rinne UK, Klinger M, Stamm G, eds. Parkinson's disease: current progress, problems, and management. Amsterdam: Elsevier, 1980:369-76.
34. Tasker RR. Siqueira J, Hawrylyshyn P, et al. What happened to VIM-thalamotomy for Parkinson's disease? Appl Neuroplysiol 1983;46:68-83.
35. Gildenberg PL. The present role of stereotactic surgery in the management of Parkinson's disease. Adv Neurol 1984;40:447-52.
36. Nagaseki Y, Shibazaki T, Hirai T, et al. Long-term follow-up results of selective VIM-thalamotomy. J Neurosurg 1986;65: 296-302.
37. Narabayashi H. Stereotaxic VIM thalamotomy for treatment of tremor. Eur Neurol 1989;29:29-32.
38. Fox MW, Ahlskog JE, Kelly PJ. Stereotactic ventrolateralis thalamotomy for medically refractory tremor in post-levodopa era Parkinson's disease patients [see comments]. J Neurosurg 1991;75:723-30.
39. Jankovic J, Cardoso F, Grossman RG, et al. Outcome after stereotactic thalamotomy for parkinsonian, essential, and other types of tremor. Neurosurgery 1995;37:680-6.
40. Benabid AL, Pollak P, Seigneuret E, et al. Chronic VIM thalamic stimulation in Parkinson's disease, essential tremor and extra-pyramidal dyskinesias. Acta Neurochir 1993;58: 39-44.